The Massachusetts Life Sciences Center (MLSC) is a quasi-state agency that supports life sciences innovation, education, research & development, and commercialization. The MLSC is charged with deploying a $1.6 billion, state-funded investment initiative. Responsible for developing and executing the Commonwealth's overall investment strategy with a focus on supporting early stage companies, recruiting and retaining companies of all stages and talent, and diversifying our industry. Created and managed the $2M Seed Fund, $2M+ public-private partnership MassNextGen to support women entrepreneurs, and other investment programs for early-stage companies.Developed and managed the strategy and execution of the business development efforts that recruit and retain life science companies in the Commonwealth of Massachusetts.Oversaw $40M+ annually in the newly overhauled Capital Programs in order to drive industry partnerships with academia that target specific industry gaps. Developed $10M+ in new Women's Health-focused investment to drive innovation and industry partnership in the space.

Advised companies from venture-backed to large pharma and med device on broad commercial topics including product positioning and commercial opportunity, exit strategies, business unit and corporate growth strategies, R&D prioritization, life-cycle management, and asset and company diligence.

Managed all aspects of commercializing MIT life science technologies including technology assessment, patent prosecution, sourcing opportunities, license structuring and negotiation, license compliance and alliance management.

Supported all efforts of licensing and commercializing MIT life science technologies.

Evaluation of early stage life science technologies including patentability and commercial viability.Developed succinct, accurate and persuasive targeted marketing material for early stage life science technologies with a focus on RNAi therapeutics and delivery technologies.

Dept. of Molecular Genetics and MicrobiologyLab of Dr. Christopher SassettiHoward Hughes Medical InvestigatorInvestigated the role of cholesterol in Mycobacterium tuberculosis pathogenesis using transposon mutagenesis and next generation sequencing technology.